fulvicin u/f tab 250mg tablet
schering-plough canada inc - griseofulvin - tablet - 250mg - griseofulvin 250mg - miscellaneous antifungals
fulvicin uf tab 500mg tablet
schering-plough canada inc - griseofulvin - tablet - 500mg - griseofulvin 500mg - miscellaneous antifungals
fulvicin pg tab 330mg tablet
schering-plough canada inc - griseofulvin - tablet - 330mg - griseofulvin 330mg - miscellaneous antifungals
grisovin-fp 125mg tab tablet
roberts pharmaceutical canada inc. - griseofulvin - tablet - 125mg - griseofulvin 125mg - miscellaneous antifungals
grisovin-fp 250mg tab tablet
roberts pharmaceutical canada inc. - griseofulvin - tablet - 250mg - griseofulvin 250mg - miscellaneous antifungals
grisodin tablet
dinlas pharma epz limited p.o box 22661-00505, nairobi - griseofulvin bp - tablet - 500mg - griseofulvin
griseofulvin 500 tablets 500mg oral solid ordinary tablets
remedica ltd - griseofulvin - oral solid ordinary tablets - 500mg
griseofulvin powder- griseofulvin powder
bimeda, inc. - griseofulvin (unii: 32hrv3e3d5) (griseofulvin - unii:32hrv3e3d5) - indications equine - ringworm infection caused by trichophyton equinum and microsporum gypseum . adults - 1 packet per day (2.5 grams). yearlings - 1/2 to 1 packet per day (1.25-2.5 grams). foals - 1/2 packet per day. cases of ringworm in horses caused by t. equinum and m. gypseum should be treated with the griseofulvin powder (microsize) product for a period of not less than 10 days. responsive cases may show clinical signs of recovery in 5 to 7 days after griseofulvin therapy is initiated. in responsive cases, treatment should be continued until all infected areas are negative by appropriate culture. if cases do not respond to therapy in 3 weeks, it is recommended that the diagnosis be reevaluated. the powder may be given on a small amount of feed or in a drench.
fulcin tablets 125 milligram
zeneca limited - griseofulvin - tablets - 125 milligram
fulcin tablets 500 milligram
zeneca limited - griseofulvin - tablets - 500 milligram